As part of the collaboration, UPMC has made a $200 million commitment to ITTC, and the University will transform a century-old building at 5000 Baum Boulevard into a world-class space for labs, offices, startup companies, and industry partners.
5000 Baum represents the University’s most significant contribution thus far to strengthening a regional innovation district aimed at spurring jobs and economic growth in western Pennsylvania.
“Today opens an exciting new chapter in our ability to partner with others to advance the University of Pittsburgh’s mission of using knowledge for society’s gain,” said Pitt Chancellor Patrick Gallagher. “We are creating an unprecedented ecosystem—one that connects basic science discoveries from Pitt with life-changing advances from UPMC while leveraging the catalytic power of industry partners. It’s a combination that will transform immunotherapy care and help us tackle some of medicine’s greatest challenges.”
Caffeinated Innovation with Jeanne Cunicelli
Last Thursday, Jeanne Cunicelli, EVP at UPMC Enterprises, joined Yvonne Campos, President of Next Act Fund, and Liz Todia, Analyst at Mutual Capital Partners, on a panel at Pittsburgh’s Innovation Works to discuss women investors and firms that specifically invest in women-led and founded businesses.
Meet the team: ITTC and Translational Science at UPMC Enterprises
UPMC Enterprises will play a key role in the new UPMC Immune Transplant and Therapy Center (ITTC), a $200 million project announced Feb. 13 that is harnessing the power of the human immune system to treat and cure a wide range of diseases.